FDA Inspection 1067952 — Stason Pharmaceuticals, Inc.
The FDA completed an inspection of Stason Pharmaceuticals, Inc. on Aug 24, 2018 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Irvine, CA (United States)